NCT06937684

Brief Summary

This study investigates the safety and tolerability of early oral clear fluid intake in children aged 1-8 years undergoing elective outpatient non-gastrointestinal surgeries. Patients will be randomized to receive clear fluids either at 1 hour or 2 hours after general anesthesia. The goal is to determine whether earlier fluid intake increases the risk of postoperative vomiting (POV), or whether it can be safely tolerated in pediatric patients."

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
172

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 14, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 22, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

March 24, 2026

Status Verified

April 1, 2025

Enrollment Period

1.2 years

First QC Date

April 14, 2025

Last Update Submit

March 23, 2026

Conditions

Keywords

Perioperative fastingAmbulatory surgeryPediatric postoperative careClear fluid intakePostoperative nausea and vomiting (PONV)Pediatric anesthesia

Outcome Measures

Primary Outcomes (1)

  • Tolerability of Early Oral Clear Fluid Intake in Children

    The number of pediatric participants who are able to tolerate clear oral fluids (up to 10 ml/kg) administered 1 hour after general anesthesia without experiencing vomiting, desaturation (SpO₂ \< 94%), or other adverse events. Tolerability is defined as successful ingestion of the planned fluid volume without signs of intolerance such as nausea, vomiting, or clinical deterioration.

    From end of anesthesia to discharge (approximately 3-4 hours postoperative)

Secondary Outcomes (3)

  • Total Volume of Oral Fluids Tolerated

    Within 1 and 2 hours post-anesthesia

  • Incidence of Postoperative Vomiting

    From end of anesthesia to discharge (within approximately 4 hours)

  • Incidence of Postoperative Vomiting on Day 1 and Day 3

    Postoperative day 1 and day 3

Study Arms (2)

Early Oral Intake Group (Group E)

EXPERIMENTAL

Patients in this group will receive a maximum of 10 ml/kg of clear fluids (e.g., water or clear fruit juice) starting at 1 hour after the completion of general anesthesia.

Behavioral: Early Oral Fluid Intake

Traditional Oral Intake Group (Group T)

ACTIVE COMPARATOR

Patients in this group will receive a maximum of 10 ml/kg of clear fluids (e.g., water or clear fruit juice) starting at 2 hours after the completion of general anesthesia.

Behavioral: Traditional Oral Fluid Intake

Interventions

Participants receive clear fluids up to 10 ml/kg at 1 hour after anesthesia.

Early Oral Intake Group (Group E)

Participants receive clear fluids up to 10 ml/kg at 2 hours after anesthesia.

Traditional Oral Intake Group (Group T)

Eligibility Criteria

Age1 Year - 8 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Children aged between 1 and 8 years
  • ASA Physical Status I or II
  • Undergoing elective, outpatient, non-gastrointestinal surgery under general anesthesia
  • Expected to be discharged on the same day
  • Parent/guardian provides informed consent

You may not qualify if:

  • Emergency surgeries
  • History of gastrointestinal disorders
  • History of aspiration or recurrent vomiting
  • Children with neurodevelopmental delay
  • Intraoperative complications requiring ICU admission
  • Refusal of oral intake postoperatively

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara City Hospital Bilkent

Ankara, 06800, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Postoperative Nausea and Vomiting

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNauseaSigns and Symptoms, DigestiveSigns and SymptomsVomiting

Study Officials

  • Feyza Sever, Assoc Prof

    Ankara City Hospital Bilkent

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Only the outcomes assessor (the nurse responsible for evaluating postoperative vomiting) is blinded to the group assignments. No other study personnel, caregivers, or participants are masked in this trial.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This is a two-arm, parallel-group, randomized controlled trial. Participants will be randomly assigned to one of two groups to receive a maximum of 10 ml/kg of clear fluids either 1 hour (early group) or 2 hours (traditional group) after general anesthesia. Each participant will be assigned to only one group and will receive the intervention once.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 14, 2025

First Posted

April 22, 2025

Study Start

November 1, 2024

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

March 24, 2026

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations